JERUSALEM--(BUSINESS WIRE)--Jun. 4, 2012--
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the Goldman Sachs 33rd Annual Global Healthcare
Conference in California. Dr. Jeremy Levin, President & CEO, will
present on Tuesday, June 5, 2012.
|
What:
|
|
Teva Presentation at the Goldman Sachs 33rd Annual
Global Healthcare Conference
|
|
Who:
|
|
Dr. Jeremy Levin, President & CEO
|
|
When:
|
|
Tuesday, June 5, 2012 at 8:40 AM PT
|
|
Where:
|
|
http://cc.talkpoint.com/gold006/060512a_lr/?entity=6_SQWKIX7
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above
and register for the event (approx. 10 minutes before). An archive
of the webcast will be available on Teva's website.
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,300 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 46,000 people around the world and reached $18.3 billion
in net revenues in 2011.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin
C. Mannix, 215-591-8912
or
Israel
Tomer Amitai, 972 (3)
926-7656
or
PR:
United States
Denise Bradley,
215-591-8974
or
Israel
Shir Altay-Hagoel, 972 (3) 926-7590